What is DocSpera?
DocSpera operates at the intersection of healthcare technology and surgical efficiency. Its advanced platform is designed to address the critical needs of surgeons, ambulatory surgery centers (ASCs), and hospitals by automating care coordination and providing real-time information. This capability is crucial for managing the substantial spend within the surgical implantable supply market, estimated at over $30 billion, thereby accelerating the adoption of value-based care models and supporting the expansion of surgical volumes. The company's interoperability with over 30 EMRs and other vital systems facilitates automated data capture, enhancing the efficacy of its solutions.
How much funding has DocSpera raised?
DocSpera has raised a total of $10M across 1 funding round:
Series B
$10M
Series B (2022): $10M with participation from Pier 70 Ventures and JJDC
Key Investors in DocSpera
Pier 70 Ventures
Pier 70 Ventures is a venture capital firm that invests in innovative, impact-driven technologies, with a particular focus on the healthcare sector. They provide capital and strategic support to accelerate the growth of high-potential companies.
JJDC
While the provided domain suggests an educational institution, in the context of this funding round, JJDC is identified as an investor. Further clarification on their specific investment focus within healthcare technology would be beneficial.
What's next for DocSpera?
The recent major strategic investment signifies a pivotal moment for DocSpera, likely enabling accelerated product development, market expansion, and further integration with healthcare systems. This capital infusion is expected to bolster the company's efforts in driving value-based care initiatives and solidifying its position as a leader in surgical coordination technology. Future growth will likely involve deepening EMR partnerships and expanding its reach within the enterprise healthcare sector.
See full DocSpera company page
